Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $200,000 | $44,315 | $32,570 | $65,354 |
| - Cash | $20,549 | $4,612 | $56,409 | $84,833 |
| + Debt | $954 | $383 | $746 | $769 |
| Enterprise Value | $180,405 | $40,086 | -$23,093 | -$18,710 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$359 | -$374 | -$373 | -$195 |
| % Margin | – | – | – | – |
| EBITDA | -$35,394 | -$116,163 | -$87,593 | -$36,665 |
| % Margin | – | – | – | – |
| Net Income | -$36,184 | -$116,537 | -$87,966 | -$34,506 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.75 | -1.64 | -6.13 | -2.33 |
| % Growth | 54.3% | 73.2% | -163.1% | – |
| Operating Cash Flow | -$47,271 | -$39,527 | -$28,424 | -$28,913 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$47,271 | -$39,527 | -$28,424 | -$28,913 |